Colonic epithelial upregulation of interleukin 22 (IL-22) in patients with ulcerative colitis

Inflammatory Bowel Diseases

Volumn 16, Issue 11, 2010, Pages 1823-

  Yamamoto Furusho, Jess K ^a   Miranda Pérez, Elizabeth ^a   Fonseca Camarillo, Gabriela ^a   Sánchez Muñoz, Fausto ^a   Dominguez Lopez, Aarón ^a   Barreto Zuñiga, Rafael ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

DEXTRAN SULFATE; INTERLEUKIN 22; MESSENGER RNA;

ADAPTIVE IMMUNITY; CLINICAL ARTICLE; COLON MUCOSA; CONTROLLED STUDY; CORRELATION ANALYSIS; DEFENSE MECHANISM; HUMAN; INNATE IMMUNITY; LETTER; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECTUM BIOPSY; REMISSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL SIGNIFICANCE; ULCERATIVE COLITIS; UPREGULATION;

COLITIS, ULCERATIVE; COLON; GENE EXPRESSION; HUMANS; INTERLEUKINS; UP-REGULATION;

EID: 77958451309     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21235     Document Type: Letter

References (3)

1. Zenewicz LA, Yancopoulos GD, Valenzuela DM, et al. Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease. Immunity. 2008; 29: 947-957.
2. Sugimoto K, Ogawa A, Mizoguchi E, et al. IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis. J Clin Invest. 2008; 118: 534-544.
3. Andoh A, Zhang Z, Inatomi O, et al. Interleukin-22, a member of the IL-10 subfamily, induces inflammatory responses in colonic subepithelial myofibroblasts. Gastroenterology. 2005; 129: 969-984.